To determine whether the presence of "coarse" fibrillatory waves (Fw) 
| INTRODUCTION
Atrial fibrillation (AF) is the most common arrhythmia in the developed world and electrical cardioversion (ECV) is an established part of a rhythm control strategy for the management of AF; in European Society of Cardiology guidelines, ECV is recommended "in symptomatic patients with persistent or long-standing persistent AF as part of rhythm control therapy" (Kirchhof et al., 2016) . In the catheter ablation era of AF management, ECV is useful clinically to see if symptoms attributable to AF improve and may be considered in patients who are felt not to be suitable for catheter ablation.
The initial procedural success rate of ECV in restoring sinus rhythm (SR) is high at approximately 70%-90% (Siaplaouras, Jung, Buob, & Heisel, 2004; Van Gelder, Crijns, Van Gilst, Verwer, & Lie, 1991) . This variability is explained in part by differences in patient characteristics and in part by the definition of success. Success can be defined as maintenance of SR immediately after ECV or for several days.
However, long-term follow-up shows that only 30%-40% of patients maintain SR at 1 year (Van Gelder et al., 1991) . Predicting success of ECV has remained difficult and previous work has investigated traditional "patient" risk factors including increasing age, longer arrhythmia duration, and coronary disease, as well as ejection fraction, left atrial appendage size, P-wave dispersion, entropy of RR interval, and atrial harmonic decay (Grönberg et al., 2015; Holmqvist et al., 2006; Raitt et al., 2006; Van Gelder et al., 1991; Zohar, Kovacic, Brezocnik, & Podbregar, 2005) . However, these factors are often not strongly predictive or alternatively difficult to measure routinely in a clinical setting without specialist equipment.
Fibrillatory waves (Fw) are found of the surface 12-lead electrocardiograms (ECGs) of patients in AF (Figure 1 ). They are oscillations in amplitude around the baseline and are dependent on the magnitude of the underlying voltage. This in turn is related to structural factors-i.e. the amount of remaining viable atrial muscle, as well as electrophysiological factors-i.e. the underlying sustaining mechanism of AF and electrical atrial remodelling in that individual. Fw can be reliably categorized by maximal amplitude into either fine (<0.1 mV) or coarse (≥0.1 mV) and this is usually performed in lead II and V 1 (Peter, Morris, & McIntosh, 1966; Thurman & Janney, 1962) . They are simple to measure and are reproducible from one ECG to another over 24 hr in clinically stable patients (Xi, Sahakian, Ng, & Swiryn, 2004) .
Studies regarding the association of Fw with underlying echocardiographic parameters are inconsistent with some having reported fine Fw to be associated with larger left atrial size, more thrombus in the left atrial appendage (LAA) and lower LAA velocity, whilst others have found no effect or the opposite (Blackshear, Safford, & Pearce, 1996; Mutlu et al., 2003; Yamamoto et al., 2005) . Electrical mapping studies have shown a relationship between a coarse AF pattern on surface ECG and intrinsic organized atrial activity during AF (Saksena, Skadsberg, Rao, & Filipecki, 2005; Saksena et al., 1999) . Research has subsequently suggested that Fw amplitude is inversely correlated with age and duration of persistent AF and directly correlated with acute success of persistent AF ablation (defined as ablation until AF termination) (Nault et al., 2009 ) and chronic freedom from AF after persistent AF ablation (Zarzoso et al., 2016) . Therefore, we hypothesized that a maximal amplitude of Fw > 0.1 mV on surface ECG predicts success of ECV by acting as a simple clinical surrogate of underlying electrophysiological and structural properties.
| METHODS
We conducted a single centre retrospective observational study by examining patients' medical notes, ECGs and echocardiograms for 
| ECG analysis
Twelve-lead ECGs were performed in a standard manner using a Mortara ELI 250 electrocardiograph machine (Mortara, Milwaukee, WI, USA) using standard ECG lead placement. ECGs were obtained at 25 mm/s and at 10 mm/mV with low and high pass filters of 0.05 Hz and 100 Hz. Two blinded cardiologists independently analyzed the pre-ECV ECG. First they confirmed whether the ECG showed atrial fibrillation (AF) and then classified it as either fine or coarse based on the fibrillatory wave (Fw) amplitude. Fw were fine (fFw) if the maximal amplitude was <0.1 mV and coarse (cFw) if maximal deflection ≥ 0.1 mV as described classically (Peter et al., 1966) . Fw were examined in leads II and V 1 using callipers on standard ECG paper. When there was disagreement regarding the classification, a third cardiologist's opinion was sought as final arbiter. Post-ECV ECGs were obtained 4 hr after ECV, before discharge from hospital and at 6 weeks after ECV at follow-up appointment. These were analyzed by two independent cardiologists to ascertain if they were in sinus rhythm or AF, blinded to pre-ECV ECGs.
| ECV procedure
All patients underwent elective day-case ECV under the supervision of a cardiologist and anesthetist. ECGs were obtained prior to the procedure to confirm AF. After initiation of appropriate monitoring as prescribed by AAGBI standards, induction of anesthesia was achieved by inhaled sevoflurane. The airway was secured by insertion of a laryngeal mask airway. No routine adjunctive anti-arrhythmic medication was given periprocedure. ECV was performed using external thoracic direct current synchronized biphasic shock with pads in an 
| Statistical analysis
We estimated a sample size of 31 per arm (62 in total) would be needed to provide 80% power (p < .05 single sided) to detect a 30% change in the primary endpoint between groups (Pocock, 1983) .
Continuous results are presented as mean ± standard deviation and categorical data as counts or percentages. Analysis and comparisons of continuous data were performed using ANOVA, while the χ 2 test was used to compare categorical data. Fisher's exact test was used if χ 2 assumptions were not met. A two-sided probability level of <.05 was considered significant. Multivariate models for prediction of ECV success included terms with p value of <.1 at univariate analysis along with Fw type. All calculations were performed using SPSS 20.0 (IBM Software, Armonk, NY, USA).
| RESULTS
One hundred and thirty-eight ECVs occurred during the 8-months period. 11 sets of notes were unavailable or incomplete and 15 ECVs were for atrial flutter and excluded. Therefore, 112 ECVs for atrial fibrillation (AF) were analyzed. Of these ECVs there were 94 individual patients (51 male, 43 female). One patient had 4 ECVs and 15 patients had 2 ECVs. Each patient was individually analyzed and only their first ECV was included in the analysis. (Figure 2 ).
Overall, the mean patient age was 71.6 ± 9.3 years. Twenty-three patients (24%) had ischemic heart disease, 26 patients (28%) had clinical heart failure, 22 patients (23%) had diabetes mellitus, and 14 patients (15%) smoked. One patient had undergone a previous AF ablation and 18 patients (19%) had undergone previous ECVs. Eighty patients (85%) were on beta-blockers, 16 patients (17%) were on digoxin, 12 patients (13%) were on amiodarone, 4 patients (4%) were on calcium channel blockers, and 1 patient was on flecainide. We found that 26 patients (28%) had a defined date of onset with the mean duration of AF being 2 ± 1.3 years.
| Fibrillatory waves
All ECGs of the 94 ECVs included were analyzed. Seventeen had coarse fibrillation waves (cFW) in lead V 1 only, seven had cFw in lead II only, and eight had cFw in both leads. Therefore, 32 (34%) had cFw in a single or both leads. There was 98% agreement between the two cardiologists in defining Fw as either coarse or fine and disagreement in only 2 (2%) ECGs. Baseline demographics and echocardiography data for cFw and fFw groups are detailed in Table 1 . There were no significant differences.
There was high rate of acute success of ECV, with 90 (96%) of patients being in SR on discharge ECG. There was no difference in the maximal energy used between cFw and fFw groups (190J ± 45
vs. 203J ± 45, p = .23) or the number of shocks required (1.1 ± 0.2 vs.
1.2 ± 0.4, p = .24). were no other significant univariate predictors of SR at 6 weeks post-ECV based on standard variables we collected so further multivariate analysis was not performed (Table 2) .
| DISCUSSION
Our results show that fibrillatory waves can be easily seen and categorized on 12-lead surface ECGs of patients in AF into coarse (cFw) and fine (fFw) varieties. Our data suggest that the presence of coarse F waves is the strongest predictor of maintenance of SR at 6 weeks after ECV, independent of traditional risk factors.
The prevalence of cFw (in either or both leads II or V 1 ) in our cohort was 34%, correlating well with previous observational data from other studies in selected patients with AF (Nault et al., 2009; Thurman & Janney, 1962) . Previous work has suggested that Fw amplitude may correlate inversely with duration of AF (Nault et al., 2009; Yamamoto et al., 2005 ) and although we were unable to replicate this finding, we only had data regarding a "clear" onset of AF in 28% of patients whilst other groups studied patients later in their disease course with differences between groups in AF duration measured in years. We also did not find any correlation between cFw and left atrial size or presence of valvular disease as was suggested in the early descriptions of F-waves (Peter et al., 1966; Thurman & Janney, 1962) or in more recent publications (Nault et al., 2009; Yamamoto et al., 2005) . This may be explained due to the lengthier durations of AF experienced by those with fFw in other cohorts leading to structural remodeling. Indeed, other studies have specifically refuted the concept that fFw are associated with increased atrial size (Morganroth, Horowitz, Josephson, & Kastor, 1979; Mutlu et al., 2003) . Our results were also independent of pharmacotherapy and specifically, amiodarone use.
Intuitively, the morphology of the F waves on a surface ECG ought to come from an interplay between viable atrial muscle mass and any underlying mechanisms of AF. In one study, biatrial mapping revealed that 87% of patients with cFw on surface ECG upon AF induction in the laboratory had discrete and organized endocardial atrial electrograms whilst 88% of those with fFw showed a chaotic pattern (Saksena et al., 1999) . Whilst the specific electrophysiological mechanisms leading to persistent AF continue to be investigated, data has already suggested the presence of cFw as a marker of acute success of catheter ablation in persistent AF (Nault et al., 2009; Zarzoso et al., 2016) . Given that large-scale trials of established methods for invasive substrate modification for persistent AF have not been convincing in terms of efficacy and that "early" modification of risk factors improves AF burden and symptoms (Abed et al., 2013) , using clinical response to ECV as a marker for those selected people who may benefit from a rhythm control strategy is increasingly relevant. To that end, our study is the first to show that a simple, reproducible clinical measurement reflecting a complex underlying pathophysiological process could be a useful marker of procedural success.
Our data are limited by the fact we do not have longer follow-up.
From a clinical point of view, however, if a patient can maintain SR at 6 weeks post-ECV and has sufficient time to notice a symptomatic benefit, this may encourage a more invasive rhythm control strategy to be pursued. We did not use complex electronic methods to determine F-wave amplitude as we felt this would not be reproducible in dayto-day clinical practice. A previous study using computerized software showed that maximal Fw amplitudes of 0.07 mV provided optimum values to maximize sensitivity and specificity in terms of prediction of acute AF termination by catheter ablation (Nault et al., 2009) which is similar to the 0.1 mV surface ECG definition which has been used as a "standard" previously.
In summary, coarse fibrillatory wave activity identified simply on surface ECGs predicted maintenance of SR at 6 weeks after ECV for persistent AF, independent of traditional risk factors. This may be a simple and noninvasive adjunctive marker reflecting complex substrate dynamics, which may be useful to lend weight to the pursuit of an individualized rhythm control strategy for patients with persistent AF.
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